A detailed history of Crews Bank & Trust transactions in Abb Vie Inc. stock. As of the latest transaction made, Crews Bank & Trust holds 9,347 shares of ABBV stock, worth $2.19 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
9,347
Previous 9,682 3.46%
Holding current value
$2.19 Million
Previous $1.8 Billion 20.42%
% of portfolio
0.32%
Previous 0.28%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 22, 2025

SELL
$184.85 - $231.54 $61,924 - $77,565
-335 Reduced 3.46%
9,347 $2.16 Billion
Q2 2025

Jul 21, 2025

SELL
$170.16 - $206.27 $39,987 - $48,473
-235 Reduced 2.37%
9,682 $1.8 Billion
Q1 2025

Apr 22, 2025

SELL
$169.2 - $216.66 $33,840 - $43,332
-200 Reduced 1.98%
9,917 $2.08 Billion
Q4 2024

Jan 23, 2025

BUY
$164.99 - $203.87 $1.67 Million - $2.06 Million
10,117 New
10,117 $1.8 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Crews Bank & Trust Portfolio

Follow Crews Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crews Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Crews Bank & Trust with notifications on news.